CN1310002A - Combined Chinese and Western medicine for treating bronchial asthma - Google Patents
Combined Chinese and Western medicine for treating bronchial asthma Download PDFInfo
- Publication number
- CN1310002A CN1310002A CN01104035A CN01104035A CN1310002A CN 1310002 A CN1310002 A CN 1310002A CN 01104035 A CN01104035 A CN 01104035A CN 01104035 A CN01104035 A CN 01104035A CN 1310002 A CN1310002 A CN 1310002A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- group
- bronchial asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The medicine consists of Chinese medicine and Western medicine. Gecko, Gypsum, Placenta Hominis, Astragalus membranaceus, Rhizoma pinelliae and other 13 Chinese medicinal materials are prepared into oral Chinese medicine. Some Western medicine are used in acupoint injection. The said oral Chinese medicine liquid and the Western medicine are used simultaneously to treat bronchial asthma and this results in high cure rate, short treating period, low relapse and no toxic side effect.
Description
The present invention relates to a kind of medicine of integrative therapy bronchial asthma, specifically it is to be the medicament of the Western medicine therapeutic alliance bronchial asthma of the Chinese medicine made according to a conventional method of raw material and acupoint injection therapy with the Chinese herbal medicine.
Bronchial asthma abbreviates asthma as, it is a kind of nonspecific inflammation disease of respiratory tract, its clinical characters is ictal uncomfortable in chest, cough, the expiratory dyspnea that is wheezing sound, the prevalence of China's asthma is 0.5-2%, the area that has is up to 5%, and age of onset is lighter, in life bringing inconvenience, even caused serious burden for society and family, aspect treatment, first elect the hormone inhalation both at home and abroad at present, effective, side effect is little, but need often take, easily outbreak after the drug withdrawal, the conventional treatments of doctor trained in Western medicine is a spasmolytic, antiinflammatory, eliminate the phlegm, the cough-relieving four processes, but effect also makes the patient not satisfied, and side effect is many, and untoward reaction is common, the aminophylline that medication is general, dexamethasone, be the spasmolytic antiallergic, select the antiinflammatory medicine simultaneously for use.The aminophylline untoward reaction is more obvious, and the patient is relatively painful, some patient even be difficult to stand, dexamethasone is the hormone drug class, and often application easily causes multiple side effect, also brings many future troubles to the patient, the unsuitable prolonged application in antibiotic medicine easily develops immunity to drugs, constipation, dysbacteriosis and relapse rate height.
Purpose of the present invention is the shortcoming and deficiency in order to overcome above-mentioned prior art just, and provide a kind of is the medicine of the integrative therapy bronchial asthma of the Chinese medicine made of raw material and Western medicine acupoint injection therapy with the Chinese herbal medicine, thereby can effectively treat this kind disease, the patient is got well early.
The objective of the invention is to realize by following technical proposal:
The medicine of integrative therapy bronchial asthma is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method with following materials of weight proportions to it is characterized in that described Chinese medicine, extracts the capsule that medicinal liquid is made through concentrated, dry powder process:
The a pair of 20-40 part of dried Gecko Gypsum Fibrosum 5-15 part Placenta Hominis 5-15 part Radix Astragali 10-30 part
Rhizoma Pinelliae 5-10 part Pheretima 5-15 part Radix Glycyrrhizae 5-15 part Herba Epimedii 5-15 part
The white bamboo 10-30 of Herba Ephedrae 5-15 part Semen Armeniacae Amarum 5-15 part part Rhizoma Drynariae 5-15 part
Radix Saposhnikoviae 5-15 part Fructus Schisandrae Chinensis 5-15 part Radix Ginseng 5-15 part 10-20 Radix Ophiopogonis part
Rhizoma Dioscoreae 10-30 part Scorpio 5-15 part.
Described Western medicine is nuclear cheese, Si Qikang.
The preferred weight proportioning of each raw material of Chinese medicine of the present invention is:
The a pair of 25-35 part of dried Gecko Gypsum Fibrosum 10-15 part Placenta Hominis 8-10 part Radix Astragali 15-25 part
Rhizoma Pinelliae 8-10 part Pheretima 8-10 part Radix Glycyrrhizae 8-10 part Herba Epimedii 8-10 part
The white bamboo 15-20 of Herba Ephedrae 10-15 part Semen Armeniacae Amarum 8-10 part part Rhizoma Drynariae 8-12 part
Radix Saposhnikoviae 8-12 part Fructus Schisandrae Chinensis 8-12 part Radix Ginseng 8-12 part 15-20 Radix Ophiopogonis part
Rhizoma Dioscoreae 15-20 part Scorpio 8-12 part.
The optimum weight proportioning of each raw material of Chinese medicine of the present invention is:
20 parts of 10 parts of Radix Astragali of dried Gecko 10 parts of Placenta Hominiss of a pair of 30 parts of Gypsum Fibrosum
10 parts of 10 parts of Herba Epimedii of 10 portions of Radix Glycyrrhizaes of 10 parts of Pheretimas of the Rhizoma Pinelliae
10 parts of 20 parts of Rhizoma Drynariae of 10 parts of white bamboos of 10 parts of Semen Armeniacae Amarums of Herba Ephedrae
15 parts of 10 parts of Radix Ginsengs of 10 parts of Fructus Schisandrae Chinensis of Radix Saposhnikoviae 10 parts of Radix Ophiopogonis
10 parts of 20 portions of Scorpios of Rhizoma Dioscoreae.
As patient the time, can also in each raw material of Chinese medicine, add and also can add Herba Houttuyniae 20-40 part, Flos Lonicerae 10-30 part, poison and stick up 5-15 part, Cortex Mori 5-15 part with inflammation.
Increase Dingchuan, SHANZHONG acupoint are injected with the scorching relaxed and comfortable A that dispels when acute attack.
The patient of bronchial asthma, suppress outbreak anoxia repeatedly because of breathing heavily, the lung repeated infection, continuous contact allergy source, the adrenal cortex secretion is very not enough in of a specified duration causing, and the normal person secretes hydrocortisone 25mg every day, secrete 250mg in case of necessity, when functional disorder, acth secretion reduces, and general weakness can occur, the waist lower limb is soft, the resisting cold ability is very low.Modern medicine study thinks that bronchial asthma has the evidence of hypophysis-hypoadrenocorticism, confirm through literature survey research and pharmacological research, kidney-reinforcing drug can improve this function, illustrate that the kidney invigorating therapy meets modern medical theory, through for many years clinical practice proof its by increasing effect of adrenal cortex function, promote the body cell metabolism, improve the low situation of body's immunity, improve the nonspecific defense function of body, can resist the change and the extraneous infective agent of weather, pathological change is developed towards the direction that helps the body reparation, pass through acupoint injection therapy again, stimulating acupoint is brought about the desired sensation, dredging the meridian, QI and blood, negative and positive are regulated internal organs, therapy of combining Chinese and Western medicine, specimen is held concurrently solid, and the performance cooperative effect promotes early recovery.
Chinese medicine preparation of the present invention is according to theory of Chinese medical science, sums up in conjunction with clinical practice for many years, and wherein raw material Gecko, Radix Astragali, Pheretima, Herba Ephedrae Scorpio are monarch drug, Gypsum Fibrosum, Fructus Schisandrae Chinensis, Radix Ginseng, Radix Ophiopogonis are ministerial drug, and all the other are adjuvant, and its property of medicine is invigorating the kidney and spleen, double solid cardiopulmonary, eliminating phlegm and stopping cough, lung qi dispersing helps the kidney improving inspiration by invigorating kidney-QI, can control the body deficient syndrome, can prevent acute attack again, promptly specimen is held concurrently admittedly, prevents and treats combination again.
Acupoint injection therapy, conventional acupoint selection are Dingchuan, Danzhong, canopy, Tiantu.
Acupuncture point effect: DINGCHUAN acupoint: can relieving asthma and cough, lung qi dispersing is regulated the flow of vital energy; Point cv 20: can resolving phlegm and relieving asthma, the sending down the abnormal ascending QI cough-relieving, SHANZHONG acupoint: can the lung qi dispersing the chest stuffiness relieving, the mind calming pain relieving; TIANTU acupoint is that acupoints on Ren channel potential energy lung qi dispersing is had one's ideas straightened out sore-throat relieving eliminating stagnation, eliminating phlegm and lowering adverse QI.All caves cooperate injection to play the effect of lowering the adverse-rising QI to subdue asthma expectorant altogether.
The Western medicine scorching relaxed and comfortable A that dispels is a hormone medicine, is used for acute attack, has antiinflammatory, anti-allergic effects, effectively controlling symptoms.Si Qikang and nuclear cheese can improve the immunity of body, prevent flu, and the two share also is that specimen is held concurrently admittedly.
Clinical drug result of the present invention:
1, materials and methods:
The 1-1 object of study:
Whole case 800 examples are according to medical history, symptom and lab testing are diagnosed as mixed type bronchial asthma, persistent state to asthma gives antiinflammatory, antibiotic, the state of an illness tides over a critical period after the oxygen uptake anti symptom treatment, divides treatment group and matched group by the random packet principle, and 200 examples are organized in treatment, man's 1 05 examples, women 95 examples, the oldest 70 years old, minimum 5 years old, 40 years old mean age, the course of disease was the longest 50 years, the shortest 2 years, merge coronary heart disease 42 examples, chronic emphysema 62 examples, pulmonary heart disease 20 examples, pulmonary infection 53 examples, contrast I group 200 examples, male 97 examples, woman's 103 examples, older 72 years old, minimum 1.5 years old, 38.7 years old mean age, the course of disease is the longest 48 years, the shortest 1 year, merge coronary disease 42 examples, chronic emphysema 62 examples, pulmonary heart disease 20 examples, pulmonary infection 57 examples; Contrast II group 200 examples, male 100 examples, women 100 examples, the oldest 71 years old, minimum 2.5 years old, 39 years old mean age, the course of disease is the longest 51 years, and was the shortest 1.5 years, merged coronary heart disease 45 examples, chronic emphysema 65 examples, pulmonary heart disease 23 examples, pulmonary infection 47 examples.Contrast III group 200 examples, male 101 examples, women 99 examples, the oldest 73 years old, minimum 3 years old, 40.5 years old mean age, the course of disease was the longest 55 years, and the shortest person 2 years merges coronary heart disease 45 examples, chronic emphysema 63 examples, pulmonary heart disease 21 examples, pulmonary infection 37 examples.
The 1-2 diagnosis basis:
1) symptoms of asthma is shown effect repeatedly, is expiratory dyspnea during outbreak;
2) family history and individual allergies are often arranged;
3) cough, cough up phlegm, breast is vexed;
4) with after the bronchiectasis medicine treatment, block situation and alleviate fully or in various degree;
5) following test can cause outbreak:
The acetylcholine inhalation test, histamine's inhalation test, exercise stress test;
6) Signs: thorax is full, be air-breathing shape, the lung increased response, the turbid boundary of liver descends, border of cardiac dullness dwindles, two lung audibles are inhaled high-pitched tone wheezing sound widely, and expiratory duration prolongs, when pulmonary infection is arranged, audible and moist rale, serious asthma attack can have the auxiliary activity of respiratory muscle, the serious asthma person's dyspnea aggravation of paradoxical pulse part, and wheezing sound alleviates middle disappearance on the contrary;
7) lab testing: eosinophilia in the blood, LgE increases;
8) increased bronchovascular shadows in the rabat, transparency increases, and heart is the shape of dangling;
9) asthma that other pathological changes causes except, as cardiac asthma, chronic asthmatic tracheitis, mediastinal tumor, spontaneous pneumothorax.
The 1-3 Therapeutic Method:
Treatment group and matched group 28 days were a course of treatment, contrasted after treating three courses of treatment, and medicine of the present invention for oral use is organized in treatment, every day three times, each 8, every 0.5g.
Acupoint injection therapy: Si Qikang, nuclear cheese, each 2ml.
Acupuncture point: Dingchuan, Danzhong, Tiantu, canopy.
Acupoint injection therapy on the three once exchanged Si Qikang, nuclear cheese every three days.
Increase Dingchuan, SHANZHONG acupoint are injected with the scorching relaxed and comfortable A that dispels when acute attack, and three once, each 2ml.
Contrast I group: oral middle medicament of the present invention, consumption serve on three courses of treatment with the treatment group.
Contrast II group: acupoint injection therapy, with treatment group consumption and method.
Contrast III group: conventional Western medicine aminophylline 0.25g adds 5% glucose 500ml, cefradine number added quiet of 0.9% sodium chloride 250ml 7-10 days, oral again cefalexin, a 0.5g, four times on the one, take spasmolytic such as ammonia tea sign indicating number alkali, powerful expectorant spirit, Radix Glycyrrhizae tabellae simultaneously, the scorching drug dosage of dispelling is by generally oral in the explanation, removes antibiotics a course of treatment, continue with other reduce phlegm, the spasmolytic medicine.
2 therapeutic outcomes: use X 2 test, ask the P value, following seven point plan contrast:
2-1, treatment are after seven days, and prolonged expiration is accompanied the variation of high-pitched tone wheezing sound in the auscultation:
See Table 1:
Compare with contrast III group: X
2There is higher significant difference=53.75 P＜0.01.
Table 1
Group \ sign disappears and reduces the no change total
Example (%) example (%) example (%)
Treatment group: 150 (75) 42 (21) 8 (4) 200
Contrast I group: 125 (62.5) 39 (19.5) 36 (18) 200
Contrast II group: 107 (53.5) 37 (18.5) 56 (28) 200
Contrast III group: 101 (50.5) 35 (17.5) 64 (32) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=20.22 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=43.52 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=53.75 P＜0.01.
The change of 2-2, treatment amount of expectoration after seven days: is patient's the amount of spitting 1 minute by every 5ml, and with the change situation of integration method mensuration amount of expectoration, 0 is divided into recovery from illness, and 1-10 is divided into improvement, little for changing more than 11 minutes, sees Table 2.
Table 2
Group 0 fen 1-10 of sign divide more than 11 minutes and add up to
Example (%) example (%) example (%)
Treatment group: 130 (65) 60 (30) 10 (5) 200
Contrast I group: 89 (44.5) 37 (18.5) 74 (37) 200
Contrast II group: 101 (50.5) 35 (17.5) 64 (32) 200
Contrast III group: 87 (43.5) 35 (17.5) 78 (39) 200
Contrast II group: 101 (50.5) 35 (17.5) 64 (32) 200
Contrast III group: 87 (43.5) 35 (17.5) 78 (39) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=61.87 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=49.60 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=67.60 P＜0.01.
Eosinophilic granulocyte's change sees Table 3 in 2-3, a treatment bleeding from anus course of treatment
Table 3
Normal (≤5%) higher (〉=6%) of group \ chemical examination adds up to
Example (%) example (%)
Treatment group: 182 (91) 18 (9) 200
Contrast I group: 131 (65.5) 69 (34.5) 200
Contrast II group: 140 (50.5) 60 (30) 200
Contrast III group: 127 (43.5) 73 (36.5) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=38.19 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=26.83 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=43.02 P＜0.01.
The change of IgE sees Table 4 in 2-4, a treatment bleeding from anus course of treatment
Table 4
Group \ chemical examination normal (≤0.9mg/100hp serum) is higher, and (〉=1.0mg/100hp serum adds up to
Example (%) example (%)
Treatment group: 192 (96) 8 (4) 200
Contrast I group: 147 (73.5) 53 (26.5) 200
Contrast II group: 135 (67.5) 65 (32.5) 200
Contrast III group: 13 (68.5) 63 (31.5) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=39.17 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=54.42 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=51.79 P＜0.01.
The change of 2-5, treatment vital capacity three courses of treatment: see Table 5
Normal vital capacity is 2400-4000ml
On the low side is 10001ml≤vital capacity≤24001ml
Difference is 300≤vital capacity＜1000ml
Table 5
Group the normally low difference of vital capacity add up to
Example (%) example (%) example (%)
Treatment group: 155 (75.5) 37 (18.5) 8 (4) 200
Contrast I group: 110 (55) 37 (19.5) 53 (26.5) 200
Contrast II group: 115 (57.5) 34 (17) 51 (25.5) 200
Contrast III group: 103 (51.5) 29 (14.5) 68 (34) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=40.83 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=37.36 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=58.8 P＜0.01.
The change of 2-6 treatment lung marking and transparency after three months sees Table 6:
In our treatment, to comparing with the rabat for the treatment of three courses of treatment before the patient treatment, improvement along with patient's lung marking and transparency, the heart external form is also changed into normal morphology by original suspended pattern, in the table rabat lung lung marking and transparency improvement situation is divided into normally, alleviates, three kinds of no changes.
Table 6:
Group \ rabat normally alleviates invalid total
Example (%) example (%) example (%)
Treatment group: 172 (86) 20 (10) 8 (4) 200
Contrast I group: 110 (55) 30 (15) 60 (30) 200
Contrast II group: 106 (53) 30 (17) 64 (32) 200
Contrast III group: 100 (51.5) 29 (14.5) 71 (35.5) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=55.36 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=61.22 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=70.92 P＜0.01.
2-7 with remembering 3 years, recurs the comparison of situation: see Table 7 to whole patients
Group \ morbidity is sent out back mild symptoms recurrence and is added up to
Example (%) example (%) example (%)
Treatment group: 164 (82) 26 (13) 10 (5) 200
Contrast I group: 93 (46.5) 20 (10) 87 (43.5) 200
Contrast II group: 85 (42.5) 17 (8.5) 98 (49) 200
Contrast III group: 37 (18.5) 12 (6) 151 (75.5) 200
The treatment group compares with contrast I group: X
2There is higher significant difference=82.84 P＜0.01.
The treatment group compares with contrast II group: X
2There is higher significant difference=102.38 P＜0.01.
The treatment group compares with contrast III group: X
2There is higher significant difference=206.79 P＜0.01.
Relatively taking Chinese Medicine and Clavicular acupoint injection therapy of the present invention treatment bronchial asthma by above seven aspects more all has higher significant difference with other three kinds of Therapeutic Method, has confirmed that medicine of the present invention is meaningful to treating bronchitis in clinical practice.
The present invention compares following advantage of tool and effect with technology:
A) medicine of the present invention is the invigorating the kidney and spleen with Chinese medicine, double solid cardiopulmonary, the deficient syndrome of can effecting a permanent cure can prevent acute attack again, accomplish that promptly specimen is double solid, the control combination by acupoint injection therapy dredging the meridian, QI and blood, negative and positive, is regulated internal organs, the Chinese and western medicine synergism, promote the early recovery of disease, greatly improve the immunity of body, prevent recurrence.
B) patient paid a return visit in 3 years, did not find toxic and side effects, and relapse rate 46%;
C) combination science, rationally, preparation method is simple;
D) consumption is few, instant effect, and cure rate 91.3%, effective percentage reaches more than 98%.
Embodiment 1:
Get a pair of 30g of dried Gecko, Gypsum Fibrosum 10g, Placenta Hominis 10g, Radix Astragali 20g, Rhizoma Pinelliae 10g, Pheretima 10g, Radix Glycyrrhizae 10g, Herba Epimedii 10g, Herba Ephedrae 10g, Semen Armeniacae Amarum 10g, Bai Zhu 20g, Rhizoma Drynariae 10g, Radix Saposhnikoviae 10g, Fructus Schisandrae Chinensis 10g, Radix Ginseng 10g, Radix Ophiopogonis 15g, Rhizoma Dioscoreae 20g, Scorpio 10g carries out decocting according to a conventional method after the mixing, extract medicinal liquid and make capsule through concentrated, dry powder process, every 0.5g, packing inspection is qualified to be product.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels.
Embodiment 2:
Get a pair of 20g of dried Gecko, Gypsum Fibrosum 5g, Placenta Hominis 15g, Radix Astragali 30g, Rhizoma Pinelliae 5g, Pheretima 15g, Radix Glycyrrhizae 5g, Herba Epimedii 5g, Herba Ephedrae 15g, Semen Armeniacae Amarum 5g, Bai Zhu 30g, Rhizoma Drynariae 5g, Radix Saposhnikoviae 15g, Fructus Schisandrae Chinensis 5g, Radix Ginseng 15g, Radix Ophiopogonis 10g, Rhizoma Dioscoreae 30g, Scorpio 5g carries out decocting according to a conventional method after the mixing, extract medicinal liquid and make capsule through concentrated, dry powder process, every 0.5g, packing inspection is qualified to be product.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels
Embodiment 3:
Get a pair of 40g of dried Gecko, Gypsum Fibrosum 15g, Placenta Hominis 5g, Radix Astragali 10g, Rhizoma Pinelliae 10g, Pheretima 5g, Radix Glycyrrhizae 15g, Herba Epimedii 15g, Herba Ephedrae 5g, Semen Armeniacae Amarum 15g, Bai Zhu 10g, Rhizoma Drynariae 15g, Radix Saposhnikoviae 5g, Fructus Schisandrae Chinensis 15g, Radix Ginseng 5g, Radix Ophiopogonis 20g, Rhizoma Dioscoreae 10g, Scorpio 15g carries out decocting according to a conventional method after the mixing, extract medicinal liquid and make capsule through concentrated, dry powder process, every 0.5g, packing inspection is qualified to be product.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels.
Embodiment 4:
Add Herba Houttuyniae 20g in the raw material in embodiment 1 again, Flos Lonicerae 25g, poison sticks up 10g, and Cortex Mori 10g makes capsule more as stated above.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels.
Embodiment 5:
Add Herba Houttuyniae 30g in the raw material in embodiment 2 again, Flos Lonicerae 30g, poison sticks up 5g, and Cortex Mori 15g makes capsule more as stated above.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels.
Embodiment 6:
Add Herba Houttuyniae 40g in the raw material in embodiment 3 again, Flos Lonicerae 10g, poison sticks up 15g, and Cortex Mori 5g makes capsule more as stated above.
Acupoint injection therapy nuclear cheese, Si Qikang during treatment, the acute attack increase scorching relaxed and comfortable A that dispels.
Claims (5)
1, the medicine of integrative therapy bronchial asthma is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method with following materials of weight proportions to it is characterized in that described Chinese medicine, extracts the capsule that medicinal liquid is made through concentrated, dry powder process:
The a pair of 20-40 part of dried Gecko Gypsum Fibrosum 5-15 part Placenta Hominis 5-15 part Radix Astragali 10-30 part
Rhizoma Pinelliae 5-10 part Pheretima 5-15 part Radix Glycyrrhizae 5-15 part Herba Epimedii 5-15 part
The white bamboo 10-30 of Herba Ephedrae 5-15 part Semen Armeniacae Amarum 5-15 part part Rhizoma Drynariae 5-15 part
Radix Saposhnikoviae 5-15 part Fructus Schisandrae Chinensis 5-15 part Radix Ginseng 5-15 part 10-20 Radix Ophiopogonis part
Rhizoma Dioscoreae 10-30 part Scorpio 5-15 part.
Described Western medicine is nuclear cheese, Si Qikang.
2, the medicine of integrative therapy bronchial asthma according to claim 1, it is characterized in that described Chinese medicine wherein the weight proportion of each raw material be:
The a pair of 25-35 part of dried Gecko Gypsum Fibrosum 10-15 part Placenta Hominis 8-10 part Radix Astragali 15-25 part
Rhizoma Pinelliae 8-10 part Pheretima 8-10 part Radix Glycyrrhizae 8-10 part Herba Epimedii 8-10 part
The white bamboo 15-20 of Herba Ephedrae 10-15 part Semen Armeniacae Amarum 8-10 part part Rhizoma Drynariae 8-12 part
Radix Saposhnikoviae 8-12 part Fructus Schisandrae Chinensis 8-12 part Radix Ginseng 8-12 part 15-20 Radix Ophiopogonis part
Rhizoma Dioscoreae 15-20 part Scorpio 8-12 part.
3, the medicine of integrative therapy bronchial asthma according to claim 1, it is characterized in that described Chinese medicine wherein the weight proportion of each raw material be:
20 parts of 10 parts of Radix Astragali of dried Gecko 10 parts of Placenta Hominiss of a pair of 30 parts of Gypsum Fibrosum
10 parts of 10 parts of Herba Epimedii of 10 portions of Radix Glycyrrhizaes of 10 parts of Pheretimas of the Rhizoma Pinelliae
10 parts of 20 parts of Rhizoma Drynariae of 10 parts of white bamboos of 10 parts of Semen Armeniacae Amarums of Herba Ephedrae
15 parts of 10 parts of Radix Ginsengs of 10 parts of Fructus Schisandrae Chinensis of Radix Saposhnikoviae 10 parts of Radix Ophiopogonis
10 parts of 20 portions of Scorpios of Rhizoma Dioscoreae.
4, integrative therapy bronchial asthma medicine according to claim 1 is characterized in that also can adding Herba Houttuyniae 20-40 part, Flos Lonicerae 10-30 part, poison and sticks up 5-15 part, Cortex Mori 5-15 part in the raw material of Chinese medicine.
5, the medicine of integrative therapy bronchial asthma according to claim 1 is characterized in that the described Western medicine scorching relaxed and comfortable A that dispels in addition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011040351A CN1136880C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating bronchial asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011040351A CN1136880C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating bronchial asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1310002A true CN1310002A (en) | 2001-08-29 |
| CN1136880C CN1136880C (en) | 2004-02-04 |
Family
ID=4653634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011040351A Expired - Lifetime CN1136880C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating bronchial asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1136880C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711830B (en) * | 2009-12-14 | 2011-07-27 | 刘桂青 | Traditional Chinese medicine composition for treating chronic bronchitis |
| CN102441105A (en) * | 2011-12-02 | 2012-05-09 | 香河县气管炎哮喘医院 | Chinese herbal medicine for treating trachitis and asthma |
| CN103505707A (en) * | 2013-09-22 | 2014-01-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN103721231A (en) * | 2013-12-30 | 2014-04-16 | 于义琴 | Asthma injection nursing medicine and preparation method thereof |
| CN105250755A (en) * | 2015-10-19 | 2016-01-20 | 王迁 | Medicine for treating bronchitis based on traditional Chinese and western medicine therapy and preparation method of medicine |
| CN106266536A (en) * | 2016-08-23 | 2017-01-04 | 香河县气管炎哮喘医院 | A kind of Chinese medicinal capsule treating tracheitis, asthma and preparation method thereof |
| CN109893645A (en) * | 2018-11-21 | 2019-06-18 | 杨启祥 | A kind of drug of combination of Chinese tradiational and Western medicine acupoint therapy tracheitis, asthma |
-
2001
- 2001-02-19 CN CNB011040351A patent/CN1136880C/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711830B (en) * | 2009-12-14 | 2011-07-27 | 刘桂青 | Traditional Chinese medicine composition for treating chronic bronchitis |
| CN102441105A (en) * | 2011-12-02 | 2012-05-09 | 香河县气管炎哮喘医院 | Chinese herbal medicine for treating trachitis and asthma |
| CN103505707A (en) * | 2013-09-22 | 2014-01-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN103505707B (en) * | 2013-09-22 | 2015-07-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN103721231A (en) * | 2013-12-30 | 2014-04-16 | 于义琴 | Asthma injection nursing medicine and preparation method thereof |
| CN105250755A (en) * | 2015-10-19 | 2016-01-20 | 王迁 | Medicine for treating bronchitis based on traditional Chinese and western medicine therapy and preparation method of medicine |
| CN106266536A (en) * | 2016-08-23 | 2017-01-04 | 香河县气管炎哮喘医院 | A kind of Chinese medicinal capsule treating tracheitis, asthma and preparation method thereof |
| CN106266536B (en) * | 2016-08-23 | 2017-10-31 | 香河县气管炎哮喘医院 | It is a kind of to treat Chinese medicinal capsule of tracheitis, asthma and preparation method thereof |
| CN109893645A (en) * | 2018-11-21 | 2019-06-18 | 杨启祥 | A kind of drug of combination of Chinese tradiational and Western medicine acupoint therapy tracheitis, asthma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1136880C (en) | 2004-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1768812A (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
| CN1167454C (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1872235A (en) | Muskiness acesodyne ointment of chasing wind, and preparation method | |
| CN1136880C (en) | Combined Chinese and Western medicine for treating bronchial asthma | |
| CN1775274A (en) | Cough-relieving sputum-resolving medicinal composition and preparing method | |
| CN1304735A (en) | Medicine for curing chronic colitis | |
| CN1785330A (en) | Medicine for treating high blood pressure and its preparation method | |
| CN1293899C (en) | Tengdan capsule for treating hypertension | |
| CN1175885C (en) | Zibei Cough stopping granules and its preparation method | |
| CN1682896A (en) | Medicine for treating infantile inflammation of upper respiratory tract and its preparing method | |
| CN1192788C (en) | Medicine for resisting allergic reaction and its preparation method | |
| CN1136878C (en) | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1136881C (en) | Combined Chinese and Western medicine for treating pulmonary emphysema | |
| CN1157219C (en) | Medicine for treating cancer | |
| CN1899581A (en) | Medicinal composition for treating qi stagnation and cold stasis stomach-ache and its preparing method and use | |
| CN1593493A (en) | Therapy assisting agent and its preparation | |
| CN1276764C (en) | Liu-Wei-Bu-Xue granule for invigorating blood contg. six herbal medicines and its prepn. method | |
| CN1203876C (en) | Medicine for curing postpartum subinvolution of uterus and its preparation method | |
| CN1814116A (en) | Chinese medicine for treating gastric cavity ache and preparing method | |
| CN1136879C (en) | Combined Chinese and Western medicine for treating chronic bronchitis in catabasis | |
| CN1879836A (en) | A medicine for treating children's excessive blink, hyperkinetic syndrome and Tottre's syndrome and method for preparing same | |
| CN1582981A (en) | Chinese medicinal composite preparation against virus | |
| CN1263491C (en) | Capsule for treating myocarditis of coxsackie B virus type, and its prepn.method | |
| CN1250278C (en) | Oral medicine for treating dementia and feeblemindedpess |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040204 |
|
| CX01 | Expiry of patent term |